 |
| |
Heat Biologics
| 0,83 $ | +1,19% | +0,0098 $ |
In : 0,7442 € |
18:54:22 Uhr NYSE | Mehr Kurse »
WKN: A2JB4Y
ISIN: US42237K3005
US-Symbol:
HTBX
Typ: Aktie
- Push
- Intraday
- 5 Tage
- 3 Monate
- 1 Jahr
- Gesamt
Performance Heat Biologics Aktie
| 1 Woche | 1 Monat | 3 Monate | Lfd. Jahr | 1 Jahr | 3 Jahre | |
| Kurs | 0,872 $ | 1,11 $ | 1,375 $ | - | - | - |
| Änderung | -4,82% | -25,23% | -39,64% | - | - | - |
Nachrichten zur Heat Biologics Aktie
| 20.05.19 | Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference | ACCESSWIRE |
| 15.05.19 | Heat Biologics Reports First Quarter 2019 Results and Provides Corporate Update | ACCESSWIRE |
| 06.05.19 | Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai | ACCESSWIRE |
| 18.04.19 | Heat Biologics CEO to Present at the ThinkEquity Conference in New York City | ACCESSWIRE |
| 02.04.19 | Heat Biologics Delivers Poster Presentation at the AACR Annual Meeting 2019 | ACCESSWIRE |
| 28.03.19 | Heat Biologics: Pharmaindustrie signalisiert „großes Interesse“ | sharedeals.de |
Forum zur Heat Biologics Aktie
aktivdepot: Endlich schliessen wir mal im plus.
21.05.19
Heat Biologics Aktie & Unternehmen
| Branche | Biotechnologie |
| Herkunft | USA |
| Website | www.heatbio.com |
| Aktienanzahl | 34,1 Mio. (Stand: 15.04.19) |
| Marktkap. | 25,1 Mio. € |
Dividenden
| Dividenden |
Ähnliche Aktien
| Trevena | 1,158 € | -0,04% | |
| Evofem Biosciences | 4,48 € | -2,93% | |
| Celgene | 86,49 € | +0,59% | |
| Moleculin Biotech | 0,9868 € | +1,76% | |
| Sesen Bio | 1,8416 € | +10,91% |
Zum Seitenanfang
